UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205

The American journal of pathology, 2012-12, Vol.181 (6), p.2188-2201

2012

Volltextzugriff (PDF)

Metabolic changes during prostate cancer development and progression

Journal of cancer research and clinical oncology, 2023-05, Vol.149 (5), p.2259-2270

2023

Volltextzugriff (PDF)

Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer

PloS one, 2020-08, Vol.15 (8), p.e0237248

2020

Volltextzugriff (PDF)

Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts

Oncogene, 2024-01, Vol.43 (4), p.235-247

2024

Volltextzugriff (PDF)

Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer

Oncogene, 2024-06, Vol.43 (26), p.2038-2050

2024

Volltextzugriff (PDF)

New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium

Journal of translational medicine, 2024-01, Vol.22 (1), p.71-8, Article 71

2024

Volltextzugriff (PDF)

Utilization of sperm cryopreservation in patients with testicular cancer

Journal of cancer research and clinical oncology, 2024-04, Vol.150 (4), p.201-201, Article 201

2024

Volltextzugriff (PDF)

Identification of genomic drivers for the therapeutic response of Cabozantinib in patients with metastatic renal cell carcinoma

World journal of urology, 2024-02, Vol.42 (1), p.94-94, Article 94

2024

Volltextzugriff (PDF)

Glutamine Metabolism and Prostate Cancer

Cancers, 2024-08, Vol.16 (16), p.2871

2024

Volltextzugriff (PDF)

Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines

Journal of cancer research and clinical oncology, 2022-06, Vol.148 (6), p.1313-1324

2022

Volltextzugriff (PDF)

PD-L1 mRNA Detection in Immunohistochemically Negative Patients: A Complementary Method for a Better Treatment Selection?

Anticancer research, 2023-10, Vol.43 (10), p.4365-4371

2023

Volltextzugriff (PDF)

Modulation of the Prostate Cancer Resistance Factor Hsp27 by the Chemotherapeutic Drugs Abiraterone, Cabazitaxel, Docetaxel and Enzalutamide

Anticancer research, 2024-07, Vol.44 (7), p.2815-2821

2024

Volltextzugriff (PDF)

Gelsolin Governs the Neuroendocrine Transdifferentiation of Prostate Cancer Cells and Suppresses the Apoptotic Machinery

Anticancer research, 2021-08, Vol.41 (8), p.3717-3729

2021

Volltextzugriff (PDF)

PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21

The American journal of pathology, 2012-05, Vol.180 (5), p.2097-2107

2012

Volltextzugriff (PDF)

Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines

International journal of molecular sciences, 2022-12, Vol.24 (1), p.666

2022

Volltextzugriff (PDF)

Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors

Cancer letters, 2018-10, Vol.435, p.121-126

2018

Volltextzugriff (PDF)

Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1046

2022

Volltextzugriff (PDF)

The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy

Scientific reports, 2019-03, Vol.9 (1), p.5120-5120, Article 5120

2019

Volltextzugriff (PDF)

Prostate Cancer's Silent Partners: Fibroblasts and Their Influence on Glutamine Metabolism Manipulation

International journal of molecular sciences, 2024-09, Vol.25 (17), p.9275

2024

Volltextzugriff (PDF)

SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells

Molecular cancer research, 2016-06, Vol.14 (6), p.574-585

2016

Volltextzugriff (PDF)

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways

Endocrine-related cancer, 2012-06, Vol.19 (3), p.305-319

2012

Volltextzugriff (PDF)

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells

Frontiers in oncology, 2022-02, Vol.12, p.789284

2022

Volltextzugriff (PDF)

The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the Androgen Receptor Translational Activity

Current issues in molecular biology, 2022-01, Vol.44 (2), p.597-608

2022

Volltextzugriff (PDF)

A Systematic Comparison of Antiandrogens Identifies Androgen Receptor Protein Stability as an Indicator for Treatment Response

Life (Basel, Switzerland), 2021-08, Vol.11 (9), p.874

2021

Volltextzugriff (PDF)

Therapy escape mechanisms in the malignant prostate

Seminars in cancer biology, 2015-12, Vol.35, p.133-144

2015

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(61)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205

Metabolic changes during prostate cancer development and progression

Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer

Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts

Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer

New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium

Utilization of sperm cryopreservation in patients with testicular cancer

Identification of genomic drivers for the therapeutic response of Cabozantinib in patients with metastatic renal cell carcinoma

Glutamine Metabolism and Prostate Cancer

Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines

PD-L1 mRNA Detection in Immunohistochemically Negative Patients: A Complementary Method for a Better Treatment Selection?

Modulation of the Prostate Cancer Resistance Factor Hsp27 by the Chemotherapeutic Drugs Abiraterone, Cabazitaxel, Docetaxel and Enzalutamide

Gelsolin Governs the Neuroendocrine Transdifferentiation of Prostate Cancer Cells and Suppresses the Apoptotic Machinery

PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21

Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines

Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors

Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells

The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy

Prostate Cancer's Silent Partners: Fibroblasts and Their Influence on Glutamine Metabolism Manipulation

SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells

The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the Androgen Receptor Translational Activity

A Systematic Comparison of Antiandrogens Identifies Androgen Receptor Protein Stability as an Indicator for Treatment Response

Therapy escape mechanisms in the malignant prostate

Suchergebnisse filtern